• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Blood pressure, heart rate, or the Rate Pressure Product: what is the best predictor of clinical outcome?

作者信息

Stoschitzky Kurt

机构信息

Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, A-8036 Graz, Austria.

出版信息

Eur Heart J Open. 2022 Oct 5;2(5):oeac063. doi: 10.1093/ehjopen/oeac063. eCollection 2022 Sep.

DOI:10.1093/ehjopen/oeac063
PMID:36325488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9617472/
Abstract
摘要

相似文献

1
Blood pressure, heart rate, or the Rate Pressure Product: what is the best predictor of clinical outcome?血压、心率还是心率血压乘积：哪项是临床预后的最佳预测指标？
Eur Heart J Open. 2022 Oct 5;2(5):oeac063. doi: 10.1093/ehjopen/oeac063. eCollection 2022 Sep.
2
Rate pressure product, age predicted maximum heart rate or heart rate reserve. Which one better predicts cardiovascular events following exercise stress echocardiography?心率血压乘积、年龄预测的最大心率或心率储备。哪一项能更好地预测运动负荷超声心动图后的心血管事件？
Am J Cardiovasc Dis. 2021 Aug 15;11(4):450-457. eCollection 2021.
3
Admission rate-pressure product as an early predictor for in-hospital mortality after aneurysmal subarachnoid hemorrhage.蛛网膜下腔出血后住院死亡率的早期预测指标：入院时的压力-容积乘积。
Neurosurg Rev. 2022 Aug;45(4):2811-2822. doi: 10.1007/s10143-022-01795-3. Epub 2022 Apr 29.
4
Shock index predicts mortality in geriatric trauma patients: an analysis of the National Trauma Data Bank.休克指数预测老年创伤患者的死亡率：国家创伤数据库分析。
J Trauma Acute Care Surg. 2014 Apr;76(4):1111-5. doi: 10.1097/TA.0000000000000160.
5
Rate-Pressure Product is a Novel Predictor for Short- and Long-Term Mortality in Patients with Acute Coronary Syndrome Undergoing Primary PCI/Immediate Invasive Strategy.心率-血压乘积是接受直接经皮冠状动脉介入治疗/即刻侵入性策略的急性冠状动脉综合征患者短期和长期死亡率的新预测因子。
Clin Interv Aging. 2024 Mar 23;19:571-579. doi: 10.2147/CIA.S449905. eCollection 2024.
6
Shock Index, Coronary Perfusion Pressure, and Rate Pressure Product As Predictors of Adverse Outcome After Pediatric Cardiac Surgery.休克指数、冠状动脉灌注压和心率血压乘积对儿科心脏手术后不良结局的预测价值。
Pediatr Crit Care Med. 2021 Jan 1;22(1):e67-e78. doi: 10.1097/PCC.0000000000002524.
7
Association of Early Myocardial Workload and Mortality Following Severe Traumatic Brain Injury.严重创伤性脑损伤后早期心肌做功与死亡率的关系。
Crit Care Med. 2018 Jun;46(6):965-971. doi: 10.1097/CCM.0000000000003052.
8
Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality.体外循环期间血压低于脑自动调节阈值的持续时间和幅度与主要发病率和手术死亡率相关。
J Thorac Cardiovasc Surg. 2014 Jan;147(1):483-9. doi: 10.1016/j.jtcvs.2013.07.069. Epub 2013 Sep 26.
9
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.低脉压是非缺血性心力衰竭患者死亡率和发病率的独立预测因素，但在缺血性晚期心力衰竭患者中并非如此。
Int J Cardiol. 2009 Jan 24;131(3):336-44. doi: 10.1016/j.ijcard.2007.10.023. Epub 2008 Jan 14.
10
Use of gabapentin, esmolol or their combination to attenuate haemodynamic response to laryngoscopy and intubation.使用加巴喷丁、艾司洛尔或其组合来减轻喉镜检查和气管插管引起的血流动力学反应。
Kathmandu Univ Med J (KUMJ). 2011 Oct-Dec;9(36):238-43. doi: 10.3126/kumj.v9i4.6336.

引用本文的文献

1
Combined pre-dialysis systolic blood pressure and pulse rate assessment for 1-year all-cause and cardiovascular mortality in patients on hemodialysis: a nationwide cohort study.血液透析患者透析前收缩压与脉搏率联合评估对1年全因死亡率和心血管死亡率的影响：一项全国性队列研究
Hypertens Res. 2025 May 19. doi: 10.1038/s41440-025-02231-x.
2
Prognostic Value of Nighttime Double Product in Nondialysis Chronic Kidney Disease With Hypertension.夜间双乘积在高血压非透析慢性肾脏病中的预后价值。
J Am Heart Assoc. 2023 Dec 19;12(24):e031627. doi: 10.1161/JAHA.123.031627. Epub 2023 Dec 18.
3
Impact of bisoprolol and amlodipine on cardiopulmonary responses and symptoms during exercise in patients with chronic obstructive pulmonary disease.比索洛尔和氨氯地平对慢性阻塞性肺疾病患者运动时心肺反应及症状的影响。
PLoS One. 2023 Jun 1;18(6):e0286302. doi: 10.1371/journal.pone.0286302. eCollection 2023.

本文引用的文献

1
The Birth of Cardiology: The Golden Decade.心脏病学的诞生：黄金十年。
Eur Heart J. 2021 May 1;42(17):1650-1651. doi: 10.1093/eurheartj/ehab119.
2
Recovery of rate-pressure product and cardiac mortality in coronary artery disease patients with type 2 diabetes.2 型糖尿病合并冠心病患者的心率-血压乘积和心脏死亡率的恢复。
Diabetes Res Clin Pract. 2019 Apr;150:150-157. doi: 10.1016/j.diabres.2019.03.007. Epub 2019 Mar 11.
3
Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.射血分数保留的住院心力衰竭患者的心率血压乘积及心率和收缩压成分：ASCEND-HF研究的见解
Clin Cardiol. 2018 Jul;41(7):945-952. doi: 10.1002/clc.22981. Epub 2018 Jul 17.
4
Predictive value for mortality of the double product at rest obtained by home blood pressure measurement: the Ohasama study.家庭血压测量时静息双乘积对死亡率的预测价值：大盐山研究。
Am J Hypertens. 2012 May;25(5):568-75. doi: 10.1038/ajh.2012.3. Epub 2012 Feb 9.
5
Elevated heart rate: a major risk factor for cardiovascular disease.心率升高：心血管疾病的主要危险因素。
Clin Exp Hypertens. 2004 Oct-Nov;26(7-8):637-44. doi: 10.1081/ceh-200031959.
6
Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension.心率与心率血压乘积作为高血压患者心血管风险的决定因素
Am J Hypertens. 1999 Feb;12(2 Pt 2):50S-55S. doi: 10.1016/s0895-7061(98)00280-5.
7
This day 50 years ago.五十年前的这一天。
N Engl J Med. 1995 Apr 13;332(15):1038-9. doi: 10.1056/NEJM199504133321518.
8
Hypertensive crisis since FDR--a partial victory.自富兰克林·德拉诺·罗斯福以来的高血压危机——部分胜利。
N Engl J Med. 1995 Apr 13;332(15):1029-30. doi: 10.1056/NEJM199504133321512.
9
The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.作为心绞痛患者运动期间心肌耗氧量指标的心率血压乘积
Circulation. 1978 Mar;57(3):549-56. doi: 10.1161/01.cir.57.3.549.